EIF4E and metabolic dysfunction-associated steatotic liver disease: Using a Mendelian randomization approach, single-nucleotide polymorphisms (SNPs) found in eukaryotic translation initiation factor 4E (eIF4E), a mTORC1 target, from Genome-Wide Association Studies (GWAS) demonstrated an effect on NAFLD.